One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2021-147460
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 4 |
Affiliation: Levine Cancer Institute, Medical University of Silesia, Sarah Cannon, Tennessee Oncology, Swedish Medical Center, Yale Cancer Center, Pennsylvania Hospital, Hospital of the University of Pennsylvania, City Of Hope National Medical Center, Rocky Mountain Cancer Centers, Duke University Health System, Queen Mary University of London, Oregon Health & Science University, CDG Therapeutics (United States), Moffitt Cancer Center, Florida Cancer Specialists & Research Institute, Wroclaw Medical University, Willamette Valley Cancer Institute and Research Center, Fred Hutch Cancer Center, University of Washington, The Maria Sklodowska-Curie National Research Institute of Oncology, Mountain Blue Cancer Care Center
Efficacy and Safety of Ublituximab in Combination with Umbralisib (U2) in Patients with Chronic Lymphocytic Leukemia (CLL) By Treatment Status: A Sub-Analysis of the Phase 3 Unity-CLL Study
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
